Notably, MGLL overexpression (p = 0.0007, Figure 4C) still strongly indicated poorer OS, which was also significantly associated with increased tumor size and mitosis and higher GIST risk defined by both the NCCN and NIH schemes (Figure 4D; all p < 0.0001). This evidence concerns the gene MGLL and gastrointestinal stromal tumor.